期刊文献+

血液透析联合血液灌流治疗维持性血液透析患者营养不良-炎症反应综合征初探 被引量:15

Blood Dialysis Combined Hemoperfusion Therapy in Patients with Maintenance Hemodialysis Malnutrition-inflammatory Response Syndrome trial
下载PDF
导出
摘要 目的:针对维持性血液透析(MHD)患者营养不良-炎症反应综合征现象普遍存在而且目前为止尚无有效治疗措施的情况下,探索新的组合型治疗方式——血液透析(HD)联合血液灌流(HP)的临床疗效。方法:本院血液净化中心筛选C-反应蛋白(CRP)大于8mg/L的MHD患者20例,先HD治疗3个月,每周透析3次,之后改为HD联合HP治疗3个月,每周透析3次,其中一次为HD联合HP,再改为HD治疗3个月。于0,3,6,9月时分别抽取患者静脉血,检测各项指标并进行营养相关的体格测量和主观综合营养评估(SGA)。结果:(1)患者CRP水平在0、3、6、9月时分别为:(18.62±12.71)mg/L,(23.60±12.16)mg/L,(10.91±7.14)mg/L,(12.13±6.95)mg/L,加用HP治疗后明显下降(P<0.01),停用HP后CRP水平有所上升趋势但差异无统计学意义(P>0.05);(2)HD+HP治疗能降低Leptin、IL-8、TNF-α水平(P均<0.01),停用HP后Leptin、IL-8、TNF-α水平有所上升趋势但差异无统计学意义(P>0.05);(3)患者血清白蛋白(Alb)在0、3、6、9月时分别为(35.41±0.88)g/L,(35.49±0.96)g/L,(36.89±0.66)g/L,(36.54±0.54)g/L,差异有统计学意义(P<0.01),停用HP后Alb水平有所下降趋势但差异无统计学意义(P>0.05)。结论:HD联合HP能降低维持性血透患者CRP水平及部分中分子毒素水平,提高维持性血透患者Alb水平,从而改善其营养状况。 Objective:Malnutrition -inflammatory reaction syndrome phenomenon exists generally in hemodialysis patients and so far there is no effective treatment measures, explore new combination treatments - blood dialysis combined hemoperfusion clini- cal curative effect. Methods: Our blood purification center the maintenance hemodialysis patients for screening C - reaction protein more than 8 mg/L in 20 patients with maintenance hemodialysis, first hemodialysis for 3 months, weekly dialysis three times, and then to hemodialysis ± hemopeffusion for 3 months, weekly dialysis three times, including one for blood dialysis combined hemoperfu sion,to change HD for 3 months.. Venous blood of patients were selected in 0 m, 3 m, 6 m ,gin,testing each index and nutrition re lated physical measurements and subjective comprehensive nutrition evaluation (SGA). Results:( 1 )CRP levels in patients with 0,3, 6,9 m respectively when: ( 18.62± 12.71 ) rag/L, ( 23.60 ± 12.16 ) mg/L, ( 10. 91 ± 7.14 ) rag/L, ( 12.13 ± 6.95 ) mg/L, add with HP decrease after treatment( P 〈0.01 ), after discontinuation HP CRP level increased trend but no statistical significance (P 〉 O. 05 ). (2) HD ± HP treatment can reduce Leptin, IL - 8, TNF alpha level(P 〈 0.01 ), after discontinuation HP Leptin, IL - 8, TNF al- pha level increased trend but no statistical significance ( P 〉 O. 05 ) . ( 3 ) Patients serum albumin (Alb) at 0 m, 3 m, 6 m,9 m, when were ( 35.41 ± 0.88 ) g/L, ( 35.49 ± 0.96 ) g/L, ( 36.89 ± 0.66 ) g/L, ( 36.54 ± 0.54 ) g/L, there is significant difference( P 〈 0.01 ), After discontinuation HP Alb level declined trend but no statistical significance ( P 〉 0.05 ). (4) Combined hemopeffusion after can improve nutritional status of the patients. Condusion:HD combined HP can reduce the maintenance hemodialysis patients CRP level and part molecule toxins level so as to improve the maintenance hemodialysis patients AIb level, improve the nutritional status. Joint HP to improve the nutritional status of important reason to may and inflammatory medium and molecular toxin removal relevant.
出处 《中国中西医结合肾病杂志》 2012年第12期1075-1078,共4页 Chinese Journal of Integrated Traditional and Western Nephrology
关键词 血液透析 营养不良-炎症反应综合征组合治疗方式 Hemodialysis Malnutrition - inflammatory reaction syndrome Combination treatments
  • 相关文献

参考文献11

  • 1Stevinkel P, Heimburger O, Lindholm B, et al. Are there two types of malnutrition in chronic renal failure.9 Evidence for rela- tionship between malnutrition, inflammation and athersclerosis ( MIA syndrome). Nephrol Dial Transplant, 2000,15 ( 7 ) : 953 - 960.
  • 2Pifer TB, Mccullough KP, Port FK, et al. ortality risk in hemodi- alysis patients and changes in nutritional indicators: DOPPS. Kidney Int, 2002,62 (6) : 2238 - 2245.
  • 3Tripepi G, Mallamaci F, Zoccali C. Inflammation markers, adhe- sion mecules, and all - cause and cardiovascular mortality in pa- tient with ESRD:search for the best risk marker by multivariate modeling. J Am Sac Nephrol,2005,16(5 ) :583 -588.
  • 4Rashid Qureali A, Aluestrand A, Divino -Filho JC, et al. In- flammation, mmalnutritin, and cardiac diease as predictrs of mor- tality in hemdialysis patients. J Am Soc Nephrol,2002,13 (1); 528 - 536.
  • 5金领微,郑育,叶菡洋,周志宏,李占园,陈辉乐,毛朝鸣,戴彩香,杨筱敏.番茄红素对血液透析患者静脉铁剂诱导细胞因子的影响[J].中国中西医结合肾病杂志,2011,12(1):40-42. 被引量:1
  • 6Schiff H, Long SM, Stratakis D, et al. Effects of uhrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant,2001,16 (9) : 1863 - 1869.
  • 7Ouseph R, Hutchison CA, Ward RA. Differences in solute remov- al by two high - flux membranes of nominally similar synthetic polymers. Nephrol Dial Transplant,2008,23 (5) : 1704 - 1712.
  • 8Basile C, Libutti P, Teutonico A, et al. Uremic toxins: the case of protein - bound compounds. G ItalNefrol, 2010,27 ( 5 ) : 498 - 507.
  • 9何平,杜丰,杨旭,李德天.血液灌流对维持性血液透析患者血浆瘦素及营养状况的影响[J].中国全科医学,2010,13(8):817-818. 被引量:10
  • 10陈秀益,申志祥,夏凌燕.血液灌流联合血液透析治疗对维持性血液透析患者的短期及中期疗效观察[J].齐齐哈尔医学院学报,2011,32(15):2405-2407. 被引量:5

二级参考文献22

  • 1张建达,袁直.血液灌流材料研究进展[J].高分子通报,2006(4):23-28. 被引量:10
  • 2Avram MM, Goldwasser P, Erroa M. Predictors of survzval in continuous ambulatory peritoneal dialysis patients: the importance of pre albumin and other nutritional and metabolic markers [J]. Am J Kidney Dialysis, 1994, 23 (2): 92-96.
  • 3Carrero JJ, Aguilera A, Stenvinkel P, et al. Appetite disorders in uremia[J]. J Ren Nutr, 2008, 18 (1): 107-113.
  • 4Taskapan MC, Taskapan H, Sahin I, et al. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality [J].Ren Fail, 2007, 29 (2): 147-54.
  • 5Stenvinkel P,Barany P.Anaemia.rHuEPO resistance,and cardiovascular disease in end-stage renal failure;links to inflammation and oxidative stress.Nephrol Dial Transplant,2002,17(Suppl5):32-37.
  • 6Smimov IM,Bailey K,Flowers CH,et al.Effects of TNF-alpha and IL-1 beta on iron metabo lism by A 549 cells and influence on cyto toxicity.Am J Physiol,1999,277(2Pt1):L257-L263.
  • 7Weiss G.Iron and immunity:a double edged sword.Eur J Clin Invest,2002,32(suppl 1):70-78.
  • 8Araujo JA,Romano EL,Brito BE,et al.Iron overload augments the development of athero sclerotic lesions in rabbits.A rterioscler Thromb Vasc Biol,1995,15(8):1172-1180.
  • 9Di Mascio P,Kaiser S,Sies H.Lycopene as the most efficient biological carotenoid singlet oxygen quencher.Arch Biochem Biophys,1989,274(2):532-538.
  • 10Rissanen TH,Voutilainen S,Nyyssonen K,et al.Serum lyeopene concentrations and carotid atherosclerosis:the Kuopis Ischaemic Heart Disease Risk Factor Study.Am J Clin Nutr,2003,77(1):133-138.

共引文献13

同被引文献127

引证文献15

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部